Immunology, Virology, and Immunogenetics of Multiple Sclerosis

Immunocyte Abnormalities in Multiple Sclerosis
Different T-Cell Response to Myelin Basic Protein in Multiple Sclerosis Patients and in Healthy Subjects
Glial Cells and Products of Activated Inflammatory Cells: Implications for Pathogenesis and Treatment of Multiple Sclerosis
Intrathecal IgG Synthesis in Multiple Sclerosis: Correlation with Clinical Parameters
Loss of Reliability and Sensitivity of Agarose Isoelectric-Focusing and Quantitative Formulae in the Detection of Intrathecally Synthesized IgG in the Presence of Blood-Brain Barrier Damage
Lymphocyte Subpopulations as Markers of Disease Activity in Multiple Sclerosis
Serological Studies of Patients with Multiple Sclerosis, Controls, and Patients with Other Neurological Diseases: Antibodies to HTLV-I, HTLV-II, HIV, and STLV-III
Correlation of Oligoclonal IgG Bands and Viral Antibodies in Twins with Multiple Sclerosis
Detection of HLA Class II Restriction Fragment Length Polymorphisms in Multiple Sclerosis Using Pooled DNA Samples
HLA Studies in the Multiple Sclerosis Population
Multiple Sclerosis: Phenotypic Immunogenetic Markers and Nucleic Acid Biochemistry
Genetics in Multiple Sclerosis - with Special Emphasis on Twin Studies
Risk Factors, Course, Prognosis, and Treatment of Multiple Sclerosis
Risk Factors, Course and Prognosis of Multiple Sclerosis
Epidemiological Studies of Multiple Sclerosis in Western Norway: Possible Factors in Etiology and Prognosis
Multiple Sclerosis: Stochastic Models of Prognosis
Studies of the Natural History of Multiple Sclerosis
Space-Time Aggregation in a Small Village in Italy: Buti (Pisa)
Immunotherapy in Multiple Sclerosis: Arguments for Early Treatment
SelectiveImmunosuppression in Multiple Sclerosis
Use of Azathioprine in Multiple Sclerosis
Immunosuppression with Azathioprine in Multiple Sclerosis
Multiple Sclerosis: Preliminary Reports of a Therapeutical Trial and Magnetic Resonance Imaging Correlates
New Trends for Treatment in Multiple Sclerosis
Short Communications
Limitations of Peroxidase Staining in the Detection of CSF IgA Separated by Agarose Isoelectric Focusing
Failure to Detect Anti-HTLV-III Antibodies in Serum and CSF of 84 Neurological Patients
Absence of Serum-HTLV-I and -III Antibodies in Multiple Sclerosis Patients
Antigen Histocompatibility (HLA) in Multiple Sclerosis Patients from Gorski Kotar, Yugoslavia
Diagnostic and Predictive Value of Nonclinical Tests in Retrobulbar Optic Neuritis
Contribution of Magnetic Resonance Imaging in the Assessment of Multiple Sclerosis
Serial Evoked Potentials and Disease Progression in Multiple Sclerosis
Clinical and Immunological Findings After Treatment with Thymostimulin in Multiple Sclerosis
Treatment of Multiple Sclerosis with a Mega Dose of 6-Methylprednisolone
Long-Term Hyperbaric Oxygen in Chronic Progressive Multiple Sclerosis: A Placebo-Controlled Double-Blind Randomized Study with Evoked Potential Evaluation
Psychotherapy in Patients with Multiple Sclerosis
Cognitive Impairment in Multiple Sclerosis.